We here compared the migratory ability among glioma cells with up-regulated GSK3β activity by transfecting cells with wild-type or constitutively active forms of GSK3β, as well as down-regulated GSK3β activity by transfecting cells with inhibitory peptide GID5-6. Here, GSK3B is linked to central nervous system cancer.